Related Experiment Video
Updated: May 8, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Association between cardiovascular diseases and osteoporosis-reappraisal
1INSERM UMR 1033, Université de Lyon, Hôpital Edouard Herriot , Lyon, France .
Insights
Cardiovascular diseases and osteoporosis are linked, with each condition increasing the risk of the other. Patients with severe osteoporosis may benefit from cardiovascular assessment, and vice versa.
Area of Science:
- Bone and cardiovascular research
- Metabolic regulation and disease
Background:
- Cardiovascular diseases (CVD) and osteoporosis are significant public health concerns.
- Individuals with CVD often exhibit lower bone mineral density (BMD) and accelerated bone loss.
- Conversely, low BMD and osteoporosis are linked to an increased risk of major cardiovascular events.
Purpose of the Study:
- To explore the bidirectional association between cardiovascular diseases and osteoporosis.
- To identify shared risk factors and underlying mechanisms connecting these two conditions.
- To highlight the need for integrated clinical assessment and guidelines.
Main Methods:
- Review of studies utilizing healthcare databases and cohort data.
- Analysis of findings on bone mineral density (BMD), bone loss, and fracture risk in CVD patients.
- Examination of the association between low BMD and cardiovascular event risk.
Main Results:
- Severe cardiovascular diseases (e.g., abdominal aortic calcification, heart failure) correlate with a higher risk of osteoporotic fractures, particularly hip fractures.
- Low BMD, fragility fractures, and increased bone resorption are associated with increased risk of cardiovascular events (myocardial infarction, stroke).
- Osteocalcin may play a role in regulating both bone and cardiovascular metabolism.
Conclusions:
- A complex interplay exists between cardiovascular health and bone metabolism, influenced by shared risk factors and metabolic pathways.
- Methodological limitations in current research necessitate careful interpretation of findings.
- Clinical practice guidelines are needed to guide the assessment of cardiovascular status in osteoporosis patients and vice versa.
Abstract:
Positive association between cardiovascular diseases and osteoporosis is important because it concerns two major public health problems. Men and women with cardiovascular diseases (including severe abdominal aortic calcification (AAC) and peripheral arterial disease) tend to have lower areal and volumetric bone mineral density (BMD) as well as faster bone loss, although findings vary according to skeletal site. On one hand, severe forms of cardiovascular diseases (heart failure, myocardial infarction, hypertension, severe AAC) are associated with higher risk of osteoporotic fracture, especially hip fracture. This link was found in the studies based on healthcare databases and the cohort studies. On the other hand, low BMD, history of fragility fracture, vitamin D deficit and increased bone resorption are associated with higher risk of major cardiovascular events (myocardial infraction, stroke, cardiovascular mortality). Moreover, osteocalcin secreted by osteoblasts may be involved in the regulation of energetic and cardiovascular metabolism. The association between both pathologies depends partially on the shared risk factors, and also on the mechanisms that are involved in the regulation of bone and cardiovascular metabolism. Interpretation of the data should take into account methodological limitations: representativeness of the cohorts, quality of the registers and the information obtained from questionnaires, severity of diseases, number of events (statistical power) and their temporal closeness, availability of the information on potential confounders. It seems that patients with severe form of osteoporosis would benefit from assessment of the cardiovascular status and vice versa. However, official guidelines for the clinical practice are still lacking.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies